ClinConnect ClinConnect Logo
Search / Trial NCT05284578

The Effects of Expressive Writing and Compassionate Letter Writing on Emotional Distress Intolerance

Launched by UNIVERSITY OF WATERLOO · Mar 16, 2022

Trial Information

Current as of October 03, 2025

Completed

Keywords

ClinConnect Summary

The study consisted of two online surveys. During the first survey, participants answered a set of questionnaires. Then, they were prompted to think of an upsetting situation and the associated unpleasant emotions, and they were then randomly assigned to a brief self-compassionate writing, expressive writing, or neutral writing task. They then answered a series of questionnaires immediately after completing the writing task. During the second survey, one week later, participants answered a brief set of questionnaires.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria for University of Waterloo sample:
  • Undergraduate students with a SONA account who are high in emotional distress intolerance (i.e. a lower-than-average score on the Distress Tolerance Scale; mean based on SONA student sample)
  • Inclusion Criteria for Prolific sample:
  • Adults with a Prolific account who are high in emotional distress intolerance (i.e. a lower-than-average score on the Distress Tolerance Scale; mean based on Prolific sample)
  • First language English speakers
  • Exclusion Criteria:
  • None

About University Of Waterloo

The University of Waterloo is a leading research institution located in Ontario, Canada, known for its innovative approach to education and commitment to advancing knowledge across various disciplines. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials that aim to translate research findings into practical applications for health and wellness. Leveraging cutting-edge technology and a robust network of academic and industry partnerships, the University of Waterloo is dedicated to improving patient outcomes and fostering advancements in healthcare through rigorous scientific inquiry and ethical clinical practices.

Locations

Waterloo, Ontario, Canada

Patients applied

0 patients applied

Trial Officials

Allison Kelly, PhD

Principal Investigator

Associate professor

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials